Topics for the Danish Treatment Council's major analyses for 2022 selected

23

Nov 2021

In late October 2021, the Treatment Council (Behandlingsråd) published three topics chosen for developing the so-called major analyses (større analyser) in 2022. The selected topics include:

  • Patient-centered diabetes technology;
  • Hand-held focused ultrasound in emergency medicine;
  • Artificial intelligence (AI) as decision support for colonoscopy.

The patient-centered diabetes technology topic will cover the use of diabetes technologies to measure and regulate blood sugar for adults with type 1 diabetes, including insulin pumps and glucose meters.

The hand-held focused ultrasound in emergency medicine topic will focus on the use of ultrasound in the emergency department, ambulance, and in acute-focused examinations - as well as an overview of the selection of portable devices.

The analysis of AI as decision support for colonoscopy will review the existing knowledge in the field and consequences of application, as well as an overview of the evidence base and the algorithm behind the AI technology.

Also, potentially a fourth topic (Intelligent beds for use in intensive care units) may be added to the Treatment Council's program for 2022. The final decision to include the above-mentioned topic will be made at the Treatment Council's meeting in December 2021.

The Treatment Council is a new body for assessing treatments and health technologies that became fully operational in late May 2021. The Treatment Council is expected to prepare 2-3 major analyses annually. The analyses are based on more fundamental topics concerning treatment regimens or approaches or organization of treatment. Based on the received proposals, the Board of the Danish Regions selects 2-3 analysis topics once a year, which constitute the Council's annual program for major analyses.

The full details in Danish can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

26

Nov 2021

In early-mid November 2021, the Federal Joint Committee (G-BA) has initiated an evaluation procedure for early benefit assessment for two new cardiovascular technologies (Revivent TC™ by BioVentrix and Trilogy™ Heart Valve System by JenaValve Technology) in heart failure, and aortic valve insufficiency and stenosis, respectively.

Read more

24

Nov 2021

In October 2021, the Scottish Health Technology Group released two Innovative Medical Technology Overviews for e-health technologies. The topics were asynchronous digital dermatology appointment service (DDAS) and the Dxcover™ Brain Cancer Liquid Biopsy. Regarding DDAS, the authors concluded that the Scottish health boards should provide more data to allow for further performance and economic analyses of the DDAS. Regarding Dxcover™, the SHTG concluded that it was cost-effective, but further work to confirm its accuracy, effectiveness, safety, and cost-effectiveness is required.

Read more

22

Nov 2021

In November 2021, the National Board of Health and Welfare released an annual update of the Swedish procedure coding classification (Classification of Health Care Measures, KVÅ) that will come into force in January 2022. KVÅ includes two parts – medical procedures (KMÅ) and surgical procedures (KKÅ) divided into chapters based on anatomical principles. In 2022, six new surgical procedure codes will be introduced. Furthermore, structural changes will be made in Chapter V "Operations on the aorta, peripheral vessels, and lymphatic system," introducing two new sub-chapters with 318 new codes. A total of 53 new medical procedure codes (KMÅ) will be added.

Read more

18

Nov 2021

In October 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (genicular artery embolization for pain from knee osteoarthritis, laparoscopic renal denervation for loin pain hematuria syndrome, percutaneous endovascular forearm arteriovenous fistula creation for hemodialysis access), and one new Medical Technologies Guidance (DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography). Also, two new clinical guidelines were published.

Read more

17

Nov 2021

Since October 2021, it is necessary to have the unique device identifier (UDI) of the various models and commercial references of the devices currently on the "intra-DRG" list in order to make it possible to collect and transmit the information relating to the use of these devices in health care establishments.

Read more